| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/01/2011 | US20110213134 Synthetic membrane anchors |
| 09/01/2011 | US20110213130 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 09/01/2011 | US20110213128 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer |
| 09/01/2011 | US20110213039 Infant formulas containing docosahexaenoic acid and lutein |
| 09/01/2011 | US20110213037 Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics |
| 09/01/2011 | US20110213036 Composition for prevention of tooth hypersensitivity |
| 09/01/2011 | US20110213034 Polar Hydrophilic Prodrugs of Amphetamine and Other Stimulants and Processes for Making and Using the Same |
| 09/01/2011 | US20110213033 Skin conditioner |
| 09/01/2011 | US20110213032 Fatty acid c16: 1n7-palmitoleate a lipokine and biomarker for metabolic status |
| 09/01/2011 | US20110213031 Novel type i natural ceramide derivative and method for producing same |
| 09/01/2011 | US20110213030 External Preparation For Skin |
| 09/01/2011 | US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands |
| 09/01/2011 | US20110213028 Fatty acid mycophenolate derivatives and their uses |
| 09/01/2011 | US20110213027 Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality |
| 09/01/2011 | US20110213026 Extracts with liver-x-receptor modulators, compounds and their use especially in weight control |
| 09/01/2011 | US20110213025 Catheter Lock Solutions Utilizing Tocopherol and Mid-Chain Fatty Acids |
| 09/01/2011 | US20110213024 Two types of crystalline of pinocembrin, their preparation and their use for manufacture of pharmaceutical compositions |
| 09/01/2011 | US20110213023 Method for inhibiting production of cytokines of t helper cell type ii and/or inhibiting production of chemokines using brazilin |
| 09/01/2011 | US20110213022 Stable, water-insoluble r-(+)-alpha-lipoic acid salt useful for the treatment of diabetes mellitus and its co-morbidities |
| 09/01/2011 | US20110213021 Compositions and methods for treating nos-associated diseases |
| 09/01/2011 | US20110213020 Immunostimulant compositions comprising a nucleobase and a polysaccharide obtainable from fungi, yeast or bacteria |
| 09/01/2011 | US20110213019 Compositions and Methods for Treating Cancer, Inhibiting Proliferation, and Inducing Cell Death |
| 09/01/2011 | US20110213018 Compositions and methods for regulation of smooth muscle cells and blood pressure |
| 09/01/2011 | US20110213015 Oligonucleotidic sequences able to silence the expression of the cyclin d1-trop2 chimera and uses thereof in medical field |
| 09/01/2011 | US20110213014 Compositions and methods for topical delivery of oligonucleotides |
| 09/01/2011 | US20110213013 Complexes of Small-Interfering Nucleic Acids |
| 09/01/2011 | US20110213012 Treatment of Cancers Characterized by Chromosomal Rearrangement of the NUT Gene |
| 09/01/2011 | US20110213011 Modulation of smad3 expression |
| 09/01/2011 | US20110213010 Methods and compositions for the treatment of huntington's disease |
| 09/01/2011 | US20110213009 Adfp modulators in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 09/01/2011 | US20110213008 Pharmaceutical containing hif-1 alpha and hif-2 alpha expression inhibitor |
| 09/01/2011 | US20110213007 MicroRNAs and uses thereof |
| 09/01/2011 | US20110213006 Compositions and Methods for Treatment of Uncontrolled Cell Growth |
| 09/01/2011 | US20110213005 Methods for treating viral infections |
| 09/01/2011 | US20110213004 Method of using combination preparation comprising angiotensin-ii-receptor blocker and hmg-coa reductase inhibitor |
| 09/01/2011 | US20110213003 Substituted hydroxamic acids and uses thereof |
| 09/01/2011 | US20110213002 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 09/01/2011 | US20110213001 Pharmaceutical compositions |
| 09/01/2011 | US20110213000 N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases |
| 09/01/2011 | US20110212999 Triazole derivatives and their use as nicotinic acetylcholine receptor modulators |
| 09/01/2011 | US20110212998 Pyridine derivatives as s1p1/edg1 receptor modulators |
| 09/01/2011 | US20110212997 Piperidine-4-acetamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 09/01/2011 | US20110212996 Method to predict response to pharmacological chaperone treatment of diseases |
| 09/01/2011 | US20110212995 Compositions and methods for treating spasticity |
| 09/01/2011 | US20110212994 Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders |
| 09/01/2011 | US20110212993 Medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
| 09/01/2011 | US20110212992 Novel p2x7r antagonists and their use |
| 09/01/2011 | US20110212991 Diagnostic Test for Susceptibility to B-RAF Kinase Inhibitors |
| 09/01/2011 | US20110212990 Novel polymorph of moxifloxacin hydrochloride |
| 09/01/2011 | US20110212989 Therapeutic methods and compositions involving isoflavones |
| 09/01/2011 | US20110212988 Tacrolimus preparation for external applications |
| 09/01/2011 | US20110212987 Method of reducing cns and gastrointestinal side affects associated with long-term dextromethorphan/low-dose quinidine combination therapy |
| 09/01/2011 | US20110212986 Anti-flavivirus therapeutic |
| 09/01/2011 | US20110212985 Naltrexone Long Acting Formulations and Methods of Use |
| 09/01/2011 | US20110212984 Use of (3r)-4--3-(4-chlorophenyl) butanoic acid for treating urinary incontinence |
| 09/01/2011 | US20110212983 Platelet adp receptor inhibitors |
| 09/01/2011 | US20110212982 Administration of Dipeptidyl Peptidase Inhibitors |
| 09/01/2011 | US20110212981 Method of Determining a Chemotherapeutic Regimen Based on ERCC1 and TS Expression |
| 09/01/2011 | US20110212980 Combinations for the treatment of migraine |
| 09/01/2011 | US20110212979 Predictive marker for egfr inhibitor treatment |
| 09/01/2011 | US20110212978 Combination of ZD6474 and Pemetrexed |
| 09/01/2011 | US20110212977 P70 s6 kinase inhibitor and mtor inhibitor combination therapy |
| 09/01/2011 | US20110212976 Deuterium-enriched risperidone |
| 09/01/2011 | US20110212975 Antiviral compounds and methods of making and using thereof |
| 09/01/2011 | US20110212974 Method for identifying compounds useful for treating and/or preventing disease-associated bone loss |
| 09/01/2011 | US20110212973 Carbamate compound or salt thereof |
| 09/01/2011 | US20110212972 Compositions and Methods for Treating Female Sexual Dysfunction |
| 09/01/2011 | US20110212971 Diketo fused azolopiperidines and azolopiperazines as anti-hiv agents |
| 09/01/2011 | US20110212970 Compounds that modulate intracellular calcium |
| 09/01/2011 | US20110212969 Substituted hydroxamic acids and uses thereof |
| 09/01/2011 | US20110212968 Phenethylamide derivatives and their heterocyclic analogues |
| 09/01/2011 | US20110212967 Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors |
| 09/01/2011 | US20110212966 Antiviral agents |
| 09/01/2011 | US20110212965 Inhibitors of Histone Deacetylase |
| 09/01/2011 | US20110212964 Modulators of pharmacokinetic properties of therapeutics |
| 09/01/2011 | US20110212963 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 09/01/2011 | US20110212962 P38 map kinase inhibitors |
| 09/01/2011 | US20110212961 Pyrazole Derivatives as Kinase Inhibitors |
| 09/01/2011 | US20110212960 New compounds for the treatment of cns disorder |
| 09/01/2011 | US20110212959 Cyanoisoquinoline Compounds and Methods of Use Thereof |
| 09/01/2011 | US20110212958 Fatty acid raloxifene derivatives and their uses |
| 09/01/2011 | US20110212957 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof |
| 09/01/2011 | US20110212956 Pyrazolopyrimidines for treating CNS disorders |
| 09/01/2011 | US20110212955 Rosamine derivatives as agents for the treatment of cancer |
| 09/01/2011 | US20110212954 Alpha-lipoic acid derivatives and their use in drug preparation |
| 09/01/2011 | US20110212953 Polymorph Form II of Tanaproget |
| 09/01/2011 | US20110212952 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (vri) activity |
| 09/01/2011 | US20110212951 Human protein tyrosine phosphatase inhibitors and methods of use |
| 09/01/2011 | US20110212950 4,4-disubstituted piperidines |
| 09/01/2011 | US20110212948 Treatment of neonate foals with meloxicam |
| 09/01/2011 | US20110212947 Substituted indole compounds having nos inhibitory activity |
| 09/01/2011 | US20110212946 Quinolone Neuropeptide S Receptor Antagonists |
| 09/01/2011 | US20110212945 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 09/01/2011 | US20110212944 2-oxo-1-pyrrolidine derivatives |
| 09/01/2011 | US20110212943 Novel bridged cyclic compounds as histone deacetylase inhibitors |
| 09/01/2011 | US20110212942 Inhibitors of polo-like kinase |
| 09/01/2011 | US20110212941 Imidazoisoindole Neuropeptide S Receptor Antagonists |
| 09/01/2011 | US20110212940 S1P Receptor Modulating Compounds and Use Thereof |
| 09/01/2011 | US20110212939 Heterocyclic GPCR Agonists |
| 09/01/2011 | US20110212938 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 |